Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine

Chemical and Pharmaceutical Bulletin

Volumn 54, Issue 8, 2006, Pages 1113-1118

  Sittisombut, Chavalit ^a   Boutefnouchet, Sabrina ^a   Trinh Van Dufat, Hanh ^a   Tian, Wen ^a   Michel, Sylvie ^a   Koch, Michel ^a   Tillequin, François ^a   Pfeiffer, Bruno ^b   Pierré, Alain ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Acronycine; Benzopyranoxanthone; Cytotoxicity; Synthesis

Indexed keywords

2 HYDROXY 1 NAPHTHALENECARBOXYLIC ACID; [2,3 I]XANTHONE; ACRONINE; BENZO[A]ACRONYCINE; BENZO[A]PYRANOL[3,2 H]; BENZOPYRANOXANTHONE; CARBOXYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ACYLATION; ALKYLATION; ARTICLE; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS;

ACRONINE; ANIMALS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MOLECULAR STRUCTURE; XANTHONES;

EID: 33746775367     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.54.1113     Document Type: Article

References (31)

1. Lee K.-H., J. Biomed. Sci., 6, 236-250 (1999).
2. Bowers W. S., Am. Zool., 21, 737-742 (1981).
3. Zembower D. E., Liao S., Flavin M. T., Xu Z.-Q., Stup T. L., Buckheit R. W., Khilevich A., Mar Y. Y., Sheinkman A. K., J. Med. Chem., 40, 1005-1017 (1997).
4. Tillequin F., Michel S., Skaltsounis A.-L., "Alkaloids: Chemical and Biological Perspectives," Vol. 12, ed. by Pelletier S. W., Elsevier, New York, 1998, pp. 1-102.
5. Nguyen Tuan M., Sittisombut C., Boutefnouchet S., Lallemand M.-C., Michel S., Koch M., Tillequin F., Mazinghien R., Lansiaux A., David-Cordonnier M.-H., Pfeiffer B., Kraus-Berthier L., Léonce S., Pierré A., J. Med. Chem., 49, 3383-3394 (2006).
6. Costes N., Le Deit H., Michel S., Tillequin F., Koch M., Pfeiffer B., Renard P., Léonce S., Guilbaud N., Kraus-Berthier L., Pierré A., Atassi Gh., J. Med. Chem., 43, 2395-2402 (2000).
7. Doan Thi Mai H., Gaslonde T., Michel S., Tillequin F., Koch M., Bongui J.-B., Elomri A., Seguin E., Pfeiffer B., Renard P., David-Cordonnier M.-H., Laine W., Bailly C., Kraus-Berthier L., Léonce S., Hickman J. A., Pierré A., J. Med. Chem., 46, 3072-3082 (2003).
8. Doan Thi Mai H., Gaslonde T., Michel S., Koch M., Tillequin F., Pfeiffer B., Renard P., Kraus-Berthier L., Léonce S., Pierré A., Chem. Pharm. Bull., 52, 293-297 (2004).
9. Guilbaud N., Léonce S., Tillequin F., Koch M., Hickman J. A., Pierré A., Anti-Cancer Drugs, 13, 445-449 (2002).
10. David-Cordonnier M.-H., Laine W., Lansiaux A., Kouach M., Briand G., Pierré A., Hickman J. A., Bailly C., Biochemistry, 41, 9911-9920 (2002).
11. David-Cordonnier M.-H., Laine W., Joubert A., Tardy C., Goossens J.-F., Kouach M., Briand G., Doan Thi Mai H., Michel S., Tillequin F., Koch M., Léonce S., Pierré A., Bailly C., Eur. J. Biochem., 270, 2848-2859 (2003).
12. David-Cordonnier M.-H., Laine W., Kouach M., Briand G., Vezin H., Gaslonde T., Michel S., Doan Thi Mai H., Tillequin F., Koch M., Léonce S., Pierré A., Bailly C., Bioorg. Med. Chem., 12, 23-29 (2004).
13. Kupchan S. M., Streelman D. R., Sneden A. T., J. Nat. Prod., 43, 296-301 (1980).
14. Habib A. M., Ho D. K., Masuda S., McCloud T., Reddy K. S., Aboushoer M., McKenzie A., Byrn S. R., Chang C.-J., Cassady J. M., J. Org. Chem., 52, 412-418 (1987).
15. Abou-Shoer M., Boettner F. E., Chang C.-J., Cassady J. M., Phytochemistry, 27, 2795-2800 (1988).
16. Permana P. A., Ho D. K., Cassady J. M., Snapka R. M., Cancer Res., 54, 3191-3195 (1994).
17. Hansen M., Lee S.-J., Cassady J. M., Hurley L. H., J. Am. Chem. Soc., 118, 5553-5561 (1996).
18. Michel S., Seguin E., Tillequin F., Curr. Med. Chem., 9, 1689-1700 (2002).
19. David-Cordonnier M.-H., Laine W., Gaslonde T., Michel S., Tillequin F., Koch M., Léonce S., Pierré A., Bailly C., Curr. Med. Chem.-Anti-Cancer Agents, 4, 82-92 (2004).
20. Michel S., Gaslonde T., Tillequin F., Eur. J. Med. Chem., 39, 649-655 (2004).
21. Sittisombut C., Costes N., Michel S., Koch M., Tillequin F., Pfeiffer B., Renard P., Pierré A., Atassi Gh., Chem. Pharm. Bull., 49, 675-679 (2001).
22. Tran Thi H. A., Nguyen Thi T., Michel S., Tillequin F., Koch M., Pfeiffer B., Pierré A., Trinh Van-Dufat H., Chem. Pharm. Bull., 52, 540-545 (2004).
23. Doan Thi Mai H., Gaslonde T., Michel S., Koch M., Tillequin F., Bailly C., David- Cordonnier M.-H., Pfeiffer B., Léonce S., Pierré A., Chem. Pharm. Bull., 53, 919-922 (2005).
24. Bongui J.-B., Elomri A., Cahard D., Tillequin F., Pfeiffer B., Pierré A., Seguin E., Chem. Pharm. Bull., 53, 1540-1546 (2005).
25. Grover P. K., Shah G. D., Shah R. C., J. Chem. Soc., 1955, 3982-3985 (1955).
26. Pillai R. K. M., Naiksatam P., Johnson F., Rajagopalan R., Watts P. C., Cricchio R., Borras S., J. Org. Chem., 51, 717-723 (1986).
27. Hennion G. F., Boisselle A. P., J. Org. Chem., 26, 725-727 (1961).
28. Mikros E., Mitaku S., Skaltsounis A.-L., Libot F., Tillequin F., Koch M., Magn. Reson. Chem., 37, 498-506 (1999).
29. Rheenen V. V., Kelly R. C., Cha D. Y., Tetrahedron Lett., 1976, 1973-1976 (1976).
30. Costes N., Elomri A., Trinh Van-Dufat H., Michel S., Seguin E., Koch M., Tillequin F., Pfeiffer B., Renard P., Léonce S., Pierré A., Oncol. Res., 13, 191-197 (2003).
31. Pierré A., Kraus-Berthier L., Atassi Gh., Cros S., Poupon M. F., Lavielle G., Berlion M., Bizarri J. P., Cancer Res., 51, 2312-2318 (1991).